Related Experiment Videos
Protein surface recognition and proteomimetics: mimics of protein surface structure and function
Steven Fletcher1, Andrew D Hamilton
1Department of Chemistry, Yale University, CT 06520-8107, USA.
Current Opinion in Chemical Biology
|October 26, 2005
Summary
Designing proteomimetics offers a promising strategy to disrupt challenging protein-protein interactions (PPIs). These molecules mimic protein surfaces, showing potential in treating diseases like cancer and HIV.
Area of Science:
- Biochemistry
- Medicinal Chemistry
- Drug Discovery
Background:
- Protein-protein interactions (PPIs) are crucial in biological processes.
- PPIs often involve large surface areas (>6 nm2), making them difficult therapeutic targets.
- Disrupting PPIs is a significant challenge in drug development.
Purpose of the Study:
- To highlight the progress in designing proteomimetics for modulating PPIs.
- To showcase the potential of proteomimetics in disease treatment.
- To review successful examples of proteomimetic applications.
Main Methods:
- Design and synthesis of molecules that mimic protein surface structures.
- Utilizing diverse scaffolds such as porphyrins, calixarenes, and alpha-helical mimetics.
- Testing the efficacy of these molecules in disrupting specific PPIs.
Main Results:
- Proteomimetics have shown success in modulating significant PPIs.
- Specific examples include targeting interactions involved in cancer and HIV.
- Various molecular designs, including small molecules, have proven effective.
Conclusions:
- Proteomimetics represent a viable approach to target challenging PPIs.
- These molecules hold therapeutic potential for diseases driven by aberrant PPIs.
- Continued research in proteomimetic design is crucial for advancing drug discovery.